Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PRRS+PCV2+Myco combination
- Development stage
- Preclinical
- Lead developer
- Reber Genetics
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The PRRS+PCV2+Myco combination is a trivalent subunit vaccine being developed by Reber Genetics for the prevention of co-infections in swine. The vaccine targets three major porcine pathogens: Porcine Reproductive and Respiratory Syndrome (PRRS) virus, Porcine Circovirus Type 2 (PCV2), and Mycoplasma (specifically *Mycoplasma hyopneumoniae*). Utilizing Reber Genetics' proprietary subunit technology, which is based on principles of cancer immunotherapy, the vaccine is designed to induce broad and effective protective immunity against these economically significant diseases that contribute to the Porcine Respiratory Disease Complex (PRDC). The product is currently in the preclinical stage of development.
- Other names
- PRRS+PCV2+Myco trivalent subunit vaccinePRRSV + PCV2 + Mycoplasma subunit vaccinePRRS, PCV2, and Mycoplasma trivalent subunit vaccine
Beyond the preview
Go deeper on PRRS+PCV2+Myco combination.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PRRS+PCV2+Myco combination.